Effectdossier · gearchiveerd kwartaal
BCAX
Bicara Therapeutics Inc. Common Stock · Healthcare · Biotechnology
65Gevolgde houders
0Δ houders
22.60MGehouden aandelen
$380.21MGerapporteerde waarde
+3Nieuwe posities
−2Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +10.7% · netto nieuwe posities +1.5% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 71 | +6 | 22.19M | $658.02M | +11 | −5 |
| Q1 2026 | 68 | +4 | 22.46M | $446.36M | +8 | −5 |
| Q4 2025 | 65 | 0 | 22.60M | $380.21M | +3 | −2 |
| Q3 2025 | 13 | -1 | 12.02M | $189.85M | — | −2 |
| Q2 2025 | 12 | 0 | 11.43M | $106.16M | +3 | −3 |
| Q1 2025 | 9 | +1 | 5.34M | $69.55M | +2 | −1 |
| Q4 2024 | 8 | -3 | 5.77M | $100.60M | +1 | −4 |
| Q3 2024 | 10 | +10 | 4.16M | $105.86M | +10 | — |
Wie het bezit · Q4 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 3.35M | +24.1% | $56.33M | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 2 | Janus Henderson Group Plc | 2.65M | — | $44.48M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | BlackRock ✦ (passief) | 2.53M | +9.4% | $42.55M | 0.0% | ▲ Add | 3 | SEC ↗ ×9 |
| 4 | The Vanguard Group ✦ (passief) | 2.19M | -0.7% | $36.79M | 0.0% | ▼ Trim | 3 | SEC ↗ ×5 |
| 5 | State Street Global Advisors ✦ (passief) | 1.65M | +179.4% | $27.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Franklin Resources Inc | 1.62M | — | $27.27M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 7 | T. Rowe Price ✦ | 1.56M | -11.2% | $26.25M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 8 | Geode Capital Management ✦ (passief) | 811.40K | -2.4% | $13.66M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 9 | Citadel Advisors ✦ | 772.26K | Nieuw | $13.00M | 0.0% | New | 1 | SEC ↗ ×2 |
| 10 | FIL Ltd | 758.49K | — | $12.77M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 552.33K | +137.3% | $9.30M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 434.70K | -57.2% | $7.32M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Ensign Peak Advisors, Inc | 401.44K | — | $6.76M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Bank Of America Corp /De/ | 335.68K | — | $5.65M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 15 | Clearbridge Investments, LLC | 298.76K | — | $5.03M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Charles Schwab Investment… | 272.14K | — | $4.58M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Td Asset Management Inc | 244.63K | — | $4.12M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Northern Trust Corp | 237.11K | — | $3.99M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 19 | UBS Group AG | 192.19K | — | $3.23M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 20 | D. E. Shaw & Co. ✦ | 136.52K | Nieuw | $2.30M | 0.0% | New | 1 | SEC ↗ |
| 21 | Deutsche Bank Ag\ | 128.63K | — | $2.16M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 22 | Morgan Stanley ✦ | 109.46K | +9.4% | $1.84M | 0.0% | ▲ Add | 2 | SEC ↗ ×7 |
| 23 | Barclays Plc | 103.24K | — | $1.74M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 98.48K | +3.4% | $1.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | Bnp Paribas Financial Markets | 95.90K | — | $1.61M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Manufacturers Life Insurance… | 98.92K | — | $1.60M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Bank of New York Mellon Corp | 88.68K | — | $1.49M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 28 | Jane Street Group, Llc | 85.58K | — | $1.44M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 29 | Citigroup Inc | 66.70K | — | $1.12M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 30 | Mariner, LLC | 64.56K | — | $1.09M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Russell Investments Group, Ltd. | 56.60K | — | $952,554 | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 32 | Hrt Financial Lp | 50.15K | — | $843,000 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Norges Bank ✦ (passief) | 42.89K | Nieuw | $721,822 | 0.0% | New | 1 | SEC ↗ |
| 34 | Dimensional Fund Advisors Lp | 40.93K | — | $688,919 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 35 | Rhumbline Advisers | 40.58K | — | $683,005 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Nuveen, LLC | 38.84K | — | $653,694 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Wells Fargo & Company/Mn | 35.24K | — | $593,140 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Swiss National Bank | 32.30K | — | $543,609 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Susquehanna International Group, Llp | 30.69K | — | $516,563 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Alliancebernstein L.P. | 29.11K | — | $489,921 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Tudor Investment Corp Et Al | 27.39K | — | $460,991 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | American Century Companies Inc | 24.49K | — | $412,217 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Creative Planning | 21.83K | — | $367,466 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Invesco Ltd. | 21.01K | — | $353,531 | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 45 | Voya Investment Management Llc | 18.20K | — | $306,222 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 46 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 18.14K | — | $302,819 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 47 | California State Teachers… | 17.16K | — | $288,769 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Group One Trading Llc | 16.91K | — | $284,663 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 16.85K | -66.2% | $283,536 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 50 | Ameriprise Financial Inc | 16.03K | — | $269,818 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Legal & General Group Plc | 15.96K | — | $268,573 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 52 | Quantinno Capital Management LP | 15.16K | — | $255,227 | 0.0% | n/c | 1 | SEC ↗ |
| 53 | LPL Financial LLC | 14.28K | — | $240,383 | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Victory Capital Management Inc | 10.07K | — | $169,478 | 0.0% | n/c | 1 | SEC ↗ |
| 55 | New York State Common Retirement… | 7.50K | — | $126,225 | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Osaic Holdings, Inc. | 4.49K | — | $75,633 | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Simplex Trading, Llc | 4.17K | — | $70,130 | 0.0% | n/c | 1 | SEC ↗ |
| 58 | Mirae Asset Global Investments Co.… | 2.66K | — | $44,801 | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Cwm, Llc | 1.16K | — | $19,000 | 0.0% | n/c | 1 | SEC ↗ |
| 60 | Royal Bank Of Canada | 1.08K | — | $18,000 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 61 | Pnc Financial Services Group, Inc. | 319 | — | $5,368 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 62 | Us Bancorp \De\ | 234 | — | $3,938 | 0.0% | n/c | 1 | SEC ↗ |
| 63 | Daiwa Securities Group Inc. | 182 | — | $3,000 | 0.0% | n/c | 1 | SEC ↗ |
| 64 | Rockefeller Capital Management L.P. | 121 | — | $2,036 | 0.0% | n/c | 1 | SEC ↗ |
| 65 | UBS AM, a distinct business unit of… | 76 | — | $1,279 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Citadel Advisors | $13.00M | 0.0% |
| D. E. Shaw & Co. | $2.30M | 0.0% |
| Norges Bank | $721,822 | 0.0% |
Verlaten
| Marshall Wace | $1.77M | was 0.0% |
| Point72 Asset Management | $475,885 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 146 houders, 71.07M aandelen, $1.23B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Sep 08
Cohlhepp Ryan
Officer, Director · 14.06K aand · $320,053
Sep 08
Cohlhepp Ryan
Officer, Director · 3.44K aand · $80,663
Aug 10
Mazumdar Claire
Officer, Director · 10.00K aand · $279,750
Aug 10
Hyep Ivan
Officer · 12.50K aand · $349,591
Aug 10
Cohlhepp Ryan
Officer, Director · 18.75K aand · $524,533
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
Oct 07
SC 13G/A — T. Rowe Price Investment Management…
Aug 13
SC 13G/A — Janus Henderson Group Ltd.
Jul 27
SC 13G — BlackRock, Inc.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q4 2025 ·
Methodologie ·
Verkrijg dit via de API